Dynasil's RMD Subsidiary Awarded $3.5 Million in Technology Development Grants by The National Institute of Health

WATERTOWN, Mass., Nov. 13, 2014 /PRNewswire/ -- Dynasil Corporation of America DYSL today announced that its contract research subsidiary, RMD Inc., has received three grants totaling $3.5 million under the National Institute of Health's Small Business Innovation Research (SBIR) Program.

"RMD's world-class research continues to be on the cutting edge of new technologies," said Peter Sulick, Dynasil's Chairman of the Board, Chief Executive Officer and President.  "RMD is developing advanced radiation detection materials and predictive instrumentation for the National Institute of Health that will deliver lower cost, next generation medical imaging systems and, if developed to a commercial product, predict the onset of shock."

Two of these awards are for RMD's cutting edge research in hemodynamics.  The first award focuses on providing first responders and emergency physicians with a simple, inexpensive, easy to use system that predicts the onset of hemorrhagic shock before the patient's vital signs reach a critical stage. 

The third award will concentrate on providing a critically needed tool to monitor the development of grafted skin, bone and muscle both prior to reconstructive surgery as well as during post-surgical recovery.  "These tools emphasize RMD's commitment to providing instruments that will not only save lives but improve the quality of people's lives as well," Sulick continued.

"The Phase II research projects RMD are undertaking through these SBIR Programs exemplify some of the world's most demanding medical needs," said Kanai Shah, Ph.D., President of Dynasil's RMD subsidiary. "These Phase II grants capitalize on our technical and scientific capability in the development of scintillation materials and instrumentation.  Dynasil is proud to partner with the National Institute of Health on these initiatives."

About Dynasil
Dynasil Corporation of America DYSL develops and manufactures optical detection and analysis technology and components for the homeland security, medical and industrial markets. Combining world-class expertise in research and materials science with extensive experience in manufacturing and product development, Dynasil is commercializing products, including dual-mode radiation detection solutions for Homeland Security and commercial applications and sensors for non-destructive testing.  Dynasil has an impressive and growing portfolio of issued and pending U.S. patents.  The Company is based in Watertown, Massachusetts, with additional operations in Mass., Minn., N.Y., N.J. and the United Kingdom. More information about the Company is available at www.dynasil.com.

Safe Harbor 
This news release may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management, including, without limitation, our expectations regarding results of operations, the commercialization of our technology and the strength of our intellectual property portfolio.  These forward-looking statements may be identified by the use of words such as "plans", "intends," "may," "could," "expect," "estimate," "anticipate," "continue" or similar terms, though not all forward-looking statements contain such words.  The actual results of the future events described in such forward looking statements could differ materially from those stated in such forward looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management and technical personnel, our ability to obtain timely payment of our invoices to governmental customers, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company's 2013 Annual Report on Form 10 K, as filed on December 20, 2013, including the risk factors contained in Item 1a, the Company's Quarterly Reports on Form 10-Q filed on February 12, 2014, May 12, 2014, August 13, 2014 and from time to time in the Company's other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Patty Kehe
Corporate Secretary
Dynasil Corporation of America
Phone: (617) 668-6855
pkehe@dynasil.com

SOURCE Dynasil Corporation of America